
IO Biotech
Clinical stage biotech company developing disruptive immune therapies for immunological treatment of cancer.
Market cap
$104m
Enterprise value
$84m
Share price
$1.58 IOBT
Company register number
36474483
Authorizing premium user...
Clinical stage biotech company developing disruptive immune therapies for immunological treatment of cancer.